New Product Reduces Clinical Signs of Herpes
Pfizer Animal Health on Feb. 8 announced the release of Zylexis in the United States, which according to the company’s research prepares the horse’s immune system to function more efficiently against equine herpesvirus-1 and -4 (EHV-1 and EHV-4)
- Topics: Article, Equine Herpesvirus (EHV), Medications
Share
ADVERTISEMENT
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Share
The Horse: Your Guide To Equine Health Care is an equine publication providing the latest news and information on the health, care, welfare, and management of all equids.
Related Articles
Stay on top of the most recent Horse Health news with
